Novel heterocycle-substituted pyrimidines as inhibitors of NF-κB transcription regulation related to TNF-α cytokine release

被引:15
作者
Ha, Hyung-Ho [1 ]
Kim, Jee Seon [1 ]
Kim, B. Moon [1 ]
机构
[1] Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea
关键词
glycogen synthase kinase 3 beta; nuclear factor kappa B; anti-inflammation; TNF-alpha cytokine; heterocyclic fused ring;
D O I
10.1016/j.bmcl.2007.11.064
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Novel heterocyclic ring-substituted pyrimidines have been designed as inhibitors of glycogen synthase kinase-3 beta (GSK-3P) from the modification of known inhibitors. Several potent inhibitors exhibiting nanomolar activities were discovered against GSK-3 beta kinase as well as in an NF-kappa B reporter gene assay. Based on the results from in vitro TNF-alpha release inhibition and in vivo endotoxima, these inhibitors are expected to be useful candidates for treatment of inflammation-related diseases. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:653 / 656
页数:4
相关论文
共 20 条
[1]   Synthesis of C-6 substituted pyrazolol[1,5-α]pyridines with potent activity against herpesviruses [J].
Allen, SH ;
Johns, BA ;
Gudmundsson, KS ;
Freeman, GA ;
Boyd, FL ;
Sexton, CH ;
Selleseth, DW ;
Creech, KL ;
Moniri, KR .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (04) :944-954
[2]  
ANGELA V, 2006, J BIOL CHEM, V281, P16985
[3]   The structure of phosphorylated GSK-3β complexed with a peptide, FRATtide, that inhibits β-catenin phosphorylation [J].
Bax, B ;
Carter, PS ;
Lewis, C ;
Guy, AR ;
Bridges, A ;
Tanner, R ;
Pettman, G ;
Mannix, C ;
Culbert, AA ;
Brown, MJB ;
Smith, DG ;
Reith, AD .
STRUCTURE, 2001, 9 (12) :1143-1152
[4]   MAP kinases [J].
Chen, Z ;
Gibson, TB ;
Robinson, F ;
Silvestro, L ;
Pearson, G ;
Xu, BE ;
Wright, A ;
Vanderbilt, C ;
Cobb, MH .
CHEMICAL REVIEWS, 2001, 101 (08) :2449-2476
[5]   Glycogen synthase kinase-3β regulates NF-κB1/p105 stability [J].
Demarchi, F ;
Bertoli, C ;
Sandy, P ;
Schneider, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (41) :39583-39590
[6]   Synthesis and structure-activity relationships of novel histamine H1 antagonists:: Indolylpiperidinyl benzoic acid derivatives [J].
Fonquerna, S ;
Miralpeix, M ;
Pagès, L ;
Puig, C ;
Cardús, A ;
Antón, F ;
Cárdenas, A ;
Vilella, D ;
Aparici, M ;
Calaf, E ;
Prieto, J ;
Gras, J ;
Huerta, JM ;
Warrellow, G ;
Beleta, J ;
Ryder, H .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) :6326-6337
[7]   Signaling to NF-κB [J].
Hayden, MS ;
Ghosh, S .
GENES & DEVELOPMENT, 2004, 18 (18) :2195-2224
[8]  
Huang H.C., 2006, Drug Discov. Today.: Ther. Strateg. Nerv. Sys. Dis., V3, P613, DOI [10.1021/acs.jmedchem.0c00931, DOI 10.1016/J.DDSTR.2006.10.020]
[9]   The glamour and gloom of glycogen synthase kinase-3 [J].
Jope, RS ;
Johnson, GVW .
TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (02) :95-102
[10]   Transcription factors: A new frontier for drug discovery [J].
Manning, AM .
DRUG DISCOVERY TODAY, 1996, 1 (04) :151-160